Skip to main content
Premium Trial:

Request an Annual Quote

Fluorotechnics Seeks to Raise $861K

NEW YORK (GenomeWeb news) – Fluorotechnics plans to raise just over A$1 million ($861,000) by issuing shares at a price of A$.28 a share, and it will use the funds to strengthen its balance sheet and for sales and marketing costs, the company said on Friday.

The company said it will raise the funds through an offer to eligible shareholders of one new share for every seven shares held, and that it will raise a minimum of $678,000.

The company, which makes fluorescent stains for research and diagnostic uses, said that institutional shareholder Hunter Hall Investment Management will underwrite the rights issue with an investment of $268,000 and that Lars Utterman, a new non-executive director at the company, has committed $150,000.

The offer will close on Sep. 2, 2009.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.